Abstract 4706: Evaluating the efficacy of RAS(ON) inhibitor RMC-6236 combined with chemotherapy and other targeted therapies in 3D models involving patients with KRAS-mutated pancreatic cancerTaylor Bargenquast, Sunil Sharma, Mohan R. Kaadige et al.|Cancer Research|2025Cited by 1